Öyvind L Schönberger

Title: Öyvind L Schönberger: Innovator in Factor VIII/vWF Purification

Introduction

Öyvind L Schönberger is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of biochemistry, particularly in the purification of factor VIII and von Willebrand factor (vWF). With a total of 2 patents, his work has implications for medical treatments related to blood clotting disorders.

Latest Patents

Öyvind's latest patents include a method for purifying factor VIII/vWF complex by cation-exchange chromatography. This method involves binding the factor VIII/vWF complex from a protein solution to a cation exchanger and recovering it through step-wise elution. The recovered complex contains high-molecular vWF multimers, which are crucial for effective treatment. Another patent focuses on the purification of von Willebrand factor by cation exchanger chromatography. This method allows for the recovery of vWF at a low salt concentration, resulting in a preparation with high specific activity.

Career Highlights

Öyvind L Schönberger is associated with Baxter Aktiengesellschaft, a company known for its advancements in healthcare and medical products. His work at Baxter has been instrumental in developing methods that enhance the purification processes of vital blood components.

Collaborations

Throughout his career, Öyvind has collaborated with esteemed colleagues such as Bernhard Fischer and Artur Mitterer. These collaborations have fostered innovation and contributed to the advancement of biopharmaceutical technologies.

Conclusion

Öyvind L Schönberger's contributions to the field of biochemistry, particularly in the purification of factor VIII and von Willebrand factor, highlight his role as an influential inventor. His patents and work at Baxter Aktiengesellschaft continue to impact medical science and improve treatment options for patients with blood disorders.